Kingdon Capital Management’s OptiNose OPTN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-373,281
| Closed | -$3.42M | – | 82 |
|
|
2025
Q1 | $3.42M | Hold |
373,281
| – | – | 0.36% | 54 |
|
|
2024
Q4 | $2.49M | Sell |
373,281
-1
| -0% | -$9 | 0.36% | 63 |
|
|
2024
Q3 | $3.75M | Hold |
373,282
| – | – | 0.42% | 64 |
|
|
2024
Q2 | $5.82M | Buy |
373,282
+113,333
| +44% | +$1.9M | 0.62% | 61 |
|
|
2024
Q1 | $5.69M | Hold |
259,949
| – | – | 0.62% | 67 |
|
|
2023
Q4 | $5.03M | Buy |
259,949
+13,333
| +5% | +$243K | 0.63% | 57 |
|
|
2023
Q3 | $4.55M | Buy |
246,616
+3,334
| +1% | +$60K | 0.52% | 53 |
|
|
2023
Q2 | $4.49M | Hold |
243,282
| – | – | 0.42% | 64 |
|
|
2023
Q1 | $7.04M | Buy |
243,282
+33,333
| +16% | +$887K | 1.32% | 31 |
|
|
2022
Q4 | $5.83M | Buy |
209,949
+56,667
| +37% | +$2.15M | 1.16% | 33 |
|
|
2022
Q3 | $8.41M | Buy |
153,282
+5,949
| +4% | +$327K | 1.08% | 24 |
|
|
2022
Q2 | $8.09M | Buy |
147,333
+14,000
| +11% | +$515K | 1.37% | 22 |
|
|
2022
Q1 | $4.94M | Buy |
+133,333
| New | +$4.76M | 0.51% | 49 |
|
Kingdon Capital Management's OPTN Position: Q2 2025 in Review
Kingdon Capital Management sold out of OptiNose (OPTN) in Q2 2025, closing a stake of 373,281 shares — an estimated $3.42M sold.
Kingdon Capital Management first reported a position in OPTN in Q1 2022 and held it in 13 quarters. The position peaked at $8.41M in Q3 2022. 0 funds tracked by Wall St. Rank hold OPTN as of Q2 2025.
- Kingdon Capital Management reported no remaining OptiNose position as of Q2 2025 after selling out during the quarter.
- Kingdon Capital Management sold 373,281 OptiNose shares in Q2 2025, an estimated $3.42M.
- Kingdon Capital Management first reported a position in OptiNose in Q1 2022 and held it in 13 quarters.
- Kingdon Capital Management's OptiNose position peaked at $8.41M in Q3 2022.
- 0 funds tracked by Wall St. Rank held OptiNose as of Q2 2025.
Based on Kingdon Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.